Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients . Clinics, [S. l.], v. 66, n. 1, p. 101–106, 2011. DOI: 10.1590/S1807-59322011000100018. Disponível em: https://www.revistas.usp.br/clinics/article/view/19460.. Acesso em: 16 may. 2024.